Pain Therapeutics Inc. (PTIE)

1.11
0.01 0.89
NASDAQ : Health Technology
Prev Close 1.12
Open 1.10
Day Low/High 1.10 / 1.13
52 Wk Low/High 0.76 / 10.87
Volume 51.43K
Avg Volume 278.10K
Exchange NASDAQ
Shares Outstanding 17.22M
Market Cap 19.97M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
Harwood Feffer LLP Announces Investigation Of Pain Therapeutics, Inc.

Harwood Feffer LLP Announces Investigation Of Pain Therapeutics, Inc.

Harwood Feffer LLP ( www.hfesq.

The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Pain Therapeutics, Inc. Of Class Action Lawsuit And The Deadline Of January 31, 2012 To Seek A Lead Plaintiff Position

The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Pain Therapeutics, Inc. Of Class Action Lawsuit And The Deadline Of January 31, 2012 To Seek A Lead Plaintiff Position

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court, Western District of Texas on behalf of purchasers of Pain Therapeutics, Inc.

Faruqi & Faruqi, LLP Announces Investigation Of Pain Therapeutics, Inc.

Faruqi & Faruqi, LLP Announces Investigation Of Pain Therapeutics, Inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Pain Therapeutics, Inc.

Bronstein, Gewirtz & Grossman, LLC Investigates Miller Energy Resources, Inc.

Bronstein, Gewirtz & Grossman, LLC Investigates Miller Energy Resources, Inc.

Headline of release should read: Bronstein, Gewirtz & Grossman, LLC Investigates Pain Therapeutics, Inc.

Pain Therapeutics Inc. Stock Downgraded (PTIE)

Pain Therapeutics Inc. Stock Downgraded (PTIE)

Pain Therapeutics (Nasdaq:PTIE) has been downgraded by TheStreet Ratings from from a hold to sell.

Pain Rises On Unusually High Volume (PTIE)

Pain Rises On Unusually High Volume (PTIE)

Pain Therapeutics (Nasdaq:PTIE) is trading at unusually high volume Tuesday with 2.7 million shares changing hands. It is currently at 4.2 times its average daily volume and trading up 8 cents (+2%).

Business Highlights

Business Highlights

Business Highlights

Pain Stock Falls On Unusually High Volume (PTIE)

Pain Stock Falls On Unusually High Volume (PTIE)

Pain Therapeutics (Nasdaq:PTIE) is trading at unusually high volume Friday with 3.1 million shares changing hands. It is currently at 6.4 times its average daily volume and trading down $3.89 (-42.1%).

Futures Flatten on Tepid U.S. Data

Futures Flatten on Tepid U.S. Data

U.S. stock futures are pointing to a largely flat open as the market weighs better-than-expected May durable goods orders and ongoing efforts to address Greece's debt crisis.

10 Stocks to Watch: PTIE, PFE, SUG

10 Stocks to Watch: PTIE, PFE, SUG

Shares of Pain Therapeutics and Pfizer were falling in premarket trading Friday as U.S. regulators rejected a tamper-resistant painkiller from the companies.

Pfizer, Pain Therapeutics Drug Rejected by FDA

Pfizer, Pain Therapeutics Drug Rejected by FDA

Pfizer and Pain Therapeutics have been trying to get Remoxy, a tamper-resistant painkiller, approved for three years.

FDA Complete Response Letter Received For REMOXY

FDA Complete Response Letter Received For REMOXY

Pfizer (NYSE: PFE) and Pain Therapeutics, Inc. (NASDAQ: PTIE) announced that a Complete Response Letter was received from the U.

Pfizer, Acura Painkiller Approved by FDA

Pfizer, Acura Painkiller Approved by FDA

The Pfizer/Acura painkiller Oxecta consists of the narcotic oxycodone combined with ingredients to make the drug resistant to tampering and abuse.

A Busy Week for Six Biotech Stocks

A Busy Week for Six Biotech Stocks

Acura, Pain Therapeutics and Fibrocell deal with FDA approval decisions while Curis presents new cancer drug data.

Pain Stock Hits New 52-Week High (PTIE)

Pain Stock Hits New 52-Week High (PTIE)

Pain Therapeutics (Nasdaq:PTIE) hit a new 52-week high Thursday as it is currently trading at $10.38, above its previous 52-week high of $10.37 with 220,760 shares traded as of 11:02 a.m. ET. Average volume has been 425,100 shares over the past 30 days.

Pain Rises On Unusually High Volume (PTIE)

Pain Rises On Unusually High Volume (PTIE)

Pain Therapeutics (Nasdaq:PTIE) is trading at unusually high volume Tuesday with 1.6 million shares changing hands. It is currently at four times its average daily volume and trading up 45 cents (+4.7%).

Pain Therapeutics Inc. Stock Upgraded (PTIE)

Pain Therapeutics Inc. Stock Upgraded (PTIE)

Pain Therapeutics (Nasdaq:PTIE) has been upgraded by TheStreet Ratings from a sell to hold.

REMOXY New Drug Application Accepted By FDA

REMOXY New Drug Application Accepted By FDA

PDUFA Goal Date is June 23, 2011

Pain Therapeutics Completes Special Distribution To Shareholders

Pain Therapeutics Completes Special Distribution To Shareholders

Shareholders Receive $2.00 Cash Per Share

Pain Therapeutics Awarded $2,000,000 Research Grant

Pain Therapeutics Awarded $2,000,000 Research Grant

Non-Dilutive Funding for Cancer and Nervous System Drug Development

Biotech Winners: King Pharmaceuticals, Pain Therapeutics

Painkillers are in the biotech spotlight Tuesday, as King Pharmaceuticals sells itself to Pfizer and tiny pain medicine developer Pain Therapeutics benefits by extension.

Pfizer Adds New Partners Through King Buy

Pfizer Adds New Partners Through King Buy

Pain Therapeutics and Acura Pharmaceuticals will partner with Pfizer once the King Pharma acquisition closes.